Accessing Medical Treatment in France with NHS Overseas Support
Discover how UK patients can receive orthopaedic, cardiac, gynaecological, bariatric, digestive and other treatments in France with NHS S2 funding. ELSAN’s international patients office supports your medical and administrative steps.
Getting Medical Treatment in France with NHS Overseas Support (S2 Route)
Why do many UK patients choose ELSAN clinics for orthopaedic, cardiac and gynaecological surgery in France?
For UK residents facing long waiting times especially in specialties such as orthopaedic surgery (hip replacement, knee replacement), cardiac surgery, gynaecological surgery, and many others France has become a trusted destination. Many choose ELSAN clinics, where highly specialised teams and streamlined pathways support international patients from first contact to recovery. The NHS’s S2 Planned Treatment Route enables eligible patients to access state‑funded care in another EU or EEA country, including France.
How does the S2 route work for patients seeking advanced surgical care in France?
The S2 scheme allows patients to receive state‑funded treatment abroad when the NHS cannot provide an equivalent procedure within an acceptable timeframe. This applies to a broad range of treatments, including hip replacement, knee replacement, cardiac bypass surgery, valve procedures, gynaecological surgery, and many other specialties offered within one of the clinics of the ELSAN group.
Approval must be obtained before travelling, and care must be delivered through the French public system or a conventionné provider.
The ELSAN international patients office helps patients organise the entire medical care pathway for treatment in France.
What eligibility criteria apply across medical specialties for S2 approval?
Core NHS criteria include:
- Being ordinarily resident in England and entitled to NHS care
- Demonstrating that the NHS cannot offer the needed treatment (e.g., hip or knee prosthesis, cardiac procedure, gynaecological surgery) within a medically acceptable timeframe
- Providing clinical justification and diagnosis from a clinician
- Obtaining confirmation of treatment dates and costs from the French provider, such as one of the clinics of the ELSAN group
What is the typical treatment journey for UK patients coming to France?
The general process includes:
- UK medical evaluation confirming the need for surgery
- Contact with the ELSAN international patients office, which provides information on specialists, timelines, and estimated costs
- Submission of the S2 application to NHS England
- Receipt of the S2 certificate enabling direct payment arrangements
This ensures timely access to care, especially for patients with urgent surgical needs.
Why do patients turn to ELSAN private hospitals in France for surgery?
Patients often choose one of the clinics of the ELSAN group because of:
- Expertise in orthopaedic surgery (hip and knee replacements)
- Renowned cardiac surgery departments
- Comprehensive gynaecological surgery units
- Additional specialties including digestive surgery, bariatric, urology and more
- A dedicated international patients office assisting with all administrative steps
These strengths make ELSAN a trusted provider for high‑quality surgical care abroad. ELSAN is also the leading private hospital group in France.
What costs are covered through the NHS S2 scheme?
Covered:
- Treatment fees according to the French state healthcare system
Not covered:
- Travel, accommodation, logistics
- French statutory co‑payments
- Private room upgrades
These rules apply across most of surgical specialties.
Is the S2 scheme a reliable option for cross‑border surgical care?
Yes. Even as healthcare rules evolve, the S2 scheme remains a stable and reliable pathway for patients whose conditions such as those requiring hip or knee prostheses, cardiac surgery, gynaecological surgery, or other interventions cannot wait.
With support from an ELSAN clinic and its international patients office UK patients benefit from a smooth, fully supported pathway to timely, high‑quality treatment in France.
Article écrit le 29/12/2025, vérifié par International Patients Office